Biotech · Private company · Mercer Island, WA, US
Kineta, Inc.
SEC CIK 0001445283
Track this companyFree. Adds Kineta, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials10 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- KVA12123 - Dose EscalationPhase 2 · CancerClinicalTrials.gov · fetched Nov 12, 2026
- KVA12123 - Dose ExpansionPhase 2 · CancerClinicalTrials.gov · fetched Nov 12, 2026
- KVA12123 Plus Pembrolizumab - Dose EscalationPhase 2 · CancerClinicalTrials.gov · fetched Nov 12, 2026
- KVA12123 Plus Pembrolizumab - Dose ExpansionPhase 2 · CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- A Clinical Trial of KVA12123 [TBS-2025] Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)PHASE1_PHASE2 · COMPLETED · started Mar 3, 2023ClinicalTrials.gov NCT05708950 · fetched Nov 12, 2026
SEC filings11
- 8-K · 8-KSEC EDGAR · filed Jul 1, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 24, 2025 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 15, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 7, 2025 · fetched Nov 12, 2026
- 10-K/A · 10-K/ASEC EDGAR · filed Apr 29, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Mar 28, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Mar 7, 2025 · fetched Nov 12, 2026
- 10-K · 10-KSEC EDGAR · filed Mar 6, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Feb 10, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Dec 12, 2024 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Nov 25, 2024 · fetched Nov 12, 2026